23
Views
2
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Time–concentration profile of serum etanercept in Japanese patients with rheumatoid arthritis after treatment discontinuation before orthopedic surgery

, , , , , , , & show all
Pages 637-639 | Received 31 Mar 2010, Accepted 11 May 2010, Published online: 02 Jan 2014

References

  • Pappas DA. Treatment of rheumatoid arthritis: tumor necrosis factor inhibitors. In: Hochberg MC, Silman A, Smolen JS, Weinblat ME, Weisman MH, editors. Rheumatoid arthritis. 1st ed. Philadelphia: Mosby, an affiliate of Elsevier; 2009. p. 337–49.
  • den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol. 2007;34(4):689–95.
  • Mochizuki T, Momohara S, Ikari K, Okamoto H, Kobayashi S, Tsukahara S, et al. The serum concentration of infiiximab in cases of autologous blood donation for patients with rheumatoid arthritis. Mod Rheumatol. 2007;17(1):24–7.
  • Nestorov I, Zitnik R, DeVries T, Nakanishi AM, Wang A, Banfield C. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. Br J Clin Pharmacol. 2006;62(4):435–45.
  • Korth-Bradley JM, Rubin AS, Hanna RK, Simcoe DK, Lebsack ME. The pharmacokinetics of etanercept in healthy volunteers. Ann Pharmacother. 2000;34(2):161–4.
  • Koike R, Takeuchi T, Eguchi K, Miyasaka N. Update on the Japanese guidelines for the use of infiiximab and etanercept in rheumatoid arthritis. Mod Rheumatol. 2007;17(6):451–8.
  • Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford). 2005;44(2):157–63.
  • Rosandich PA, Kelley JT 3rd, Conn DL. Perioperative manage-ment of patients with rheumatoid arthritis in the era of biologic response modifiers. Curr Opin Rheumatol. 2004;16(3):192–8.
  • Ruyssen-Witrand A, Gossec L, Salliot C, Luc M, Duclos M, Guignard S, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol. 2007;25(3):430–6.
  • Fautrel B, Pham T, Mouterde G, Le Loet X, Goupille P, Guillemin F, et al. Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patients with rheumatoid arthritis. Joint Bone Spine. 2007;74(6):627–37.
  • Corrao S, Pistone G, Arnone S, Calvo L, Scaglione R, Licata G. Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. Clin Rheumatol. 2007;26(9):1513–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.